06/12/2015
Federal Register Notice: FDA has determined the regulatory review period for Pfizer’s Xeljanz (tofacitinib citrate) is 3,947...06/12/2015
Federal Register Notice: FDA’s proposed collection of information, “Medical Device Recall Authority — 21 CFR 810...06/12/2015
Federal Register Notice: FDA submits a proposed collection of information entitled “Reclassification Petitions for Medical D...06/12/2015
Federal Register Notice: FDA is making available a guidance for industry entitled Cell-Based Products for Animal Use. The document...06/09/2015
Federal Register Notice: FDA’s collection of information entitled “Risk and Benefit Perception Scale Development,&rdqu...06/09/2015
Federal Register Notice: FDA’s collection of information entitled “Evaluation of the Food and Drug Administration&rsqu...06/09/2015
Federal Register Notice: FDA’s collection of information entitled “Prominent and Conspicuous Mark of Manufacturers on ...06/03/2015
Federal Register Notice: FDA’s collection of information entitled, “Disclosure Regarding Additional Risks in Direct-to...